Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8801533

Cl.c1cnc2cn[nH]c2c1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 known ✓ P07900 1/20 0.45
FGFR1 known ✓ P11362 1/20 0.36
MAPK14 known ✓ Q16539 2/20 0.35
IDO1 P14902 2/20 0.45
CDK2 P24941 1/20 0.45
DYRK1A Q13627 1/20 0.44
NOS1 P29475 3/20 0.39
AXL P30530 2/20 0.39
ABCB1 P08183 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 1/20 0.38
DAO P14920 1/20 0.38
ATAD2 Q6PL18 1/20 0.38
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
TGFBR1 P36897 3/20 0.37
METAP2 P50579 1/20 0.36
TGFBR2 P37173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17559224 0.98 IDO1 (0.46) IDO1HSP90AA1CDK2DYRK1ANOS1
SCHEMBL29354958 0.98
SCHEMBL10290 0.98
Water SCHEMBL10431157 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
Calcium SCHEMBL9503277 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
Ammonia Solution, Strong SCHEMBL14894047 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
Fluoride SCHEMBL28159076 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
SCHEMBL28901431 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
SCHEMBL1434898 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1
Benzene SCHEMBL28175560 0.96 IDO1 (0.45) IDO1HSP90AA1CDK2DYRK1ANOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11266589-B2 Hair dyeing composition comprising an oxidation dye, a scleroglucan gum, and an alkylpolyglycoside L'OREAL (FR) 2022-03-08 US disclosed
US-20210236466-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2021-08-05 US disclosed
US-20210128444-A1 HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM, AND AN ALKYLPOLYGLYCOSIDE L'OREAL (FR) 2021-05-06 US disclosed
CN-108513574-B N-sulfonylated pyrazolo [3, 4-b ] pyridine-6-carboxamides and methods of use 艾伯维公司 2021-01-05 CN disclosed
CN-108513574-A N-sulfonylated pyrazolo [3,4-b ] pyridine-6-carboxamides and methods of use 艾伯维公司 2018-09-07 CN disclosed
CN-108431002-A Substituted pyrazolo [3, 4-b ] pyridine-6-carboxylic acids and uses thereof 艾伯维公司 2018-08-21 CN disclosed
CN-1042937-C Substituted fused pyrazolo compounds and their use as herbicides ZENECA LTD (GB) 1999-04-14 CN disclosed
EP-0681581-B1 SUBSTITUTED FUSED PYRAZOLO COMPOUNDS AND THEIR USE AS HERBICIDES ZENECA LTD (GB) 1997-09-10 EP disclosed
CN-1117294-A Substituted fused pyrazolo compounds and their use as herbicides ZENECA LTD (GB) 1996-02-21 CN disclosed
EP-0681581-A1 SUBSTITUTED FUSED PYRAZOLO COMPOUNDS AND THEIR USE AS HERBICIDES. ZENECA LTD (GB) 1995-11-15 EP disclosed
US-5430007-A Certain herbicidal pyrazolopyridazines ZENECA LIMITED (GB) 1995-07-04 US disclosed
WO-1994017062-A1 SUBSTITUTED FUSED PYRAZOLO COMPOUNDS AND THEIR USE AS HERBICIDES ZENECA LIMITED (GB) 1994-08-04 WO disclosed
US-5300478-A Herbicides ZENECA LIMITED (GB) 1994-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210236466-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY STING1, CGAS, IRF3 HSP90AA1 1164/4885FGFR1 2321/4885MAPK14 1913/4885
US-20210128444-A1 HAIR DYEING COMPOSITION COMPRISING AN OXIDATION DYE, A SCLEROGLUCAN GUM, AND AN ALKYLPOLYGLYCOSIDE KRT18, OGG1, ALPG HSP90AA1 3596/4885FGFR1 1967/4885MAPK14 2917/4885
US-11266589-B2 Hair dyeing composition comprising an oxidation dye, a scleroglucan gum, and an alkylpolyglycoside KRT18, OGG1, ALPG HSP90AA1 3464/4885FGFR1 3452/4885MAPK14 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.